[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608106":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":12,"collaborators":10,"id":16,"slug":17,"hasResults":18,"nctId":19,"briefTitle":20,"officialTitle":21,"acronym":10,"eligibilityCriteria":22,"healthyVolunteers":18,"sex":23,"minAge":24,"maxAge":10,"enrollmentInfo":25,"targetDuration":10,"studyType":28,"phases":10,"briefSummary":29,"conditions":30,"keywords":32,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":10},{"fullName":5,"class":6},"Assiut University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Adult patients (≥18 years old) undergoing elective PCI for stable coronary artery disease will form",null,"The targeted cohort consists of men and women presenting with stable ischemic heart disease scheduled to undergo elective PCI at the Assiut University Heart Hospital cardiac catheterization unit",{"type":13,"investigatorFullName":14,"investigatorTitle":15,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","ahmed gamal abdelhakeem ahmed","resident at Cardiology Department","100608106","prognostic-role-of-lipoproteina-in-elective-percutaneous-coronary-revascularization-100608106",false,"NCT07197242","Prognostic Role of Lipoprotein(a) in Elective Percutaneous Coronary Revascularization","Assessment of Lipoprotein(a) in Patients Undergoing Elective Percutaneous Coronary Revascularization: Implications for Cardiovascular Risk Stratification","Inclusion Criteria:\n\n* Adults aged 18 years or older\n\nUndergoing elective PCI for stable coronary artery disease\n\nAbility to provide informed consent\n\nWillingness to undergo blood sampling prior to PCI\n\nExclusion Criteria:\n\n* Acute coronary syndrome within 30 days\n\nCardiogenic shock\n\nPrior heart transplant or left ventricular assist device (LVAD)\n\nLife expectancy less than 1 year due to non-cardiac causes\n\nParticipation in a blinded Lp(a)-lowering outcome trial at the time of enrollment","ALL","18 Years",{"count":26,"type":27},156,"ESTIMATED","OBSERVATIONAL","The study investigates the role of Lipoprotein(a) \\[Lp(a)\\] levels in predicting cardiovascular risk and adverse events in patients undergoing elective percutaneous coronary intervention (PCI).",[31],"PCI",[31,33],"coronary artery disease","NOT_YET_RECRUITING","2025-09-20",{"date":37,"type":38},"2025-09-29","ACTUAL",{"date":40,"type":27},"2026-10-01",{"date":42,"type":27},"2027-12-30",{"name":5,"class":6}]